Clinical Trials - Phase III
Filter News
Found 22,528 articles
-
Eli Lilly and Company Launches Its First Phase III Trial for Treatment of Alzheimer's Disease
3/31/2008
-
Takeda Global Research & Development New Data Showed ACTOS(R) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
3/31/2008
-
NeoVista, Inc. Presents One Year Data on Novel Wet AMD Therapy
3/28/2008
-
Thallion Pharmaceuticals Inc. to Defer the Start Date of Its Phase II/III Shigamabs(R) Clinical Trial
3/27/2008
-
VIVUS, Inc. Completes Enrollment in Phase 3 EQUIP (OB-302) Trial
3/27/2008
-
Ferring Pharmaceuticals Announces Positive Phase III Data Unveiled for New GnRH Blocker Degarelix
3/27/2008
-
AEterna Zentaris Begins Second Phase 3 Trial of Cetrorelix for Benign Prostatic Hyperplasia
3/26/2008
-
Repligen Corporation Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
3/26/2008
-
Adherex Technologies Inc. Announces Phase III Trial With STS in Collaboration With the Children's Oncology Group
3/26/2008
-
Cell Therapeutics, Inc. Announces Enrollment Complete in Phase III EXTEND Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
3/25/2008
-
Cardiome Pharma Corp. Release: Circulation Publishes Data Showing KYNAPID(TM) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
3/25/2008
-
Anesiva, Inc. Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
3/25/2008
-
Accentia Biopharmaceuticals Sinusitis Drug Fails To Meet Main Goal; Stock Plummets
3/25/2008
-
Independent Data Safety Monitoring Board Supports Continuation of Alimera Sciences Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME
3/24/2008
-
pSivida Limited Release: DSMB Again Supports Continuation of the Phase III Clinical Trial of Medidur(TM) FA for the Treatment of DME
3/24/2008
-
Corcept Therapeutics Inc. Announces Commencement of Next Phase 3 Study With CORLUX(R) for the Treatment of Psychotic Depression
3/24/2008
-
Depomed, Inc. Doses First Patient in New Phase 3 Clinical Trial of Gabapentin GR in Postherpetic Neuralgia
3/24/2008
-
Accentia Biopharmaceuticals to Announce Top-Line SinuNase Phase 3 Clinical Trial Results Later Today
3/24/2008
-
Sangart, Inc. Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
3/24/2008
-
MAP Pharmaceuticals, Inc. Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product
3/24/2008